Jemmerson R, Millan J L, Klier F G, Fishman W H
FEBS Lett. 1985 Jan 7;179(2):316-20. doi: 10.1016/0014-5793(85)80542-1.
Certain monoclonal antibodies (mAbs) to human placental alkaline phosphatase (PLAP) block bromelain cleavage of a 2-kDa segment from each of the two polypeptide chains of PLAP. These mAbs also prevent the release of PLAP from cultured cancer cell surfaces by bromelain. Such proteolysis-blocking mAbs serve as tools to specifically modify the molecular topography of cell surfaces by protease treatment.
某些针对人胎盘碱性磷酸酶(PLAP)的单克隆抗体(mAb)可阻断菠萝蛋白酶对PLAP两条多肽链中每一条链上一个2 kDa片段的切割。这些mAb还可防止菠萝蛋白酶将PLAP从培养的癌细胞表面释放出来。这种蛋白水解阻断性mAb可作为通过蛋白酶处理特异性修饰细胞表面分子拓扑结构的工具。